A detailed history of Truist Financial Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Truist Financial Corp holds 34,664 shares of EW stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,664
Previous 70,395 50.76%
Holding current value
$2.57 Million
Previous $6.5 Million 64.83%
% of portfolio
0.0%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $2.13 Million - $3.35 Million
-35,731 Reduced 50.76%
34,664 $2.29 Million
Q2 2024

Aug 20, 2024

SELL
$84.3 - $94.31 $552,586 - $618,202
-6,555 Reduced 8.52%
70,395 $6.5 Million
Q1 2024

May 10, 2024

SELL
$72.54 - $95.56 $1.12 Million - $1.47 Million
-15,413 Reduced 16.69%
76,950 $7.35 Million
Q4 2023

Feb 02, 2024

SELL
$61.71 - $77.76 $3.07 Million - $3.87 Million
-49,788 Reduced 35.02%
92,363 $7.04 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $3.32 Million - $4.48 Million
47,975 Added 50.94%
142,151 $9.85 Million
Q2 2023

Aug 01, 2023

BUY
$81.41 - $94.33 $126,511 - $146,588
1,554 Added 1.68%
94,176 $8.88 Million
Q1 2023

May 05, 2023

BUY
$74.26 - $84.51 $249,142 - $283,531
3,355 Added 3.76%
92,622 $7.66 Million
Q4 2022

Feb 17, 2023

SELL
$68.3 - $87.44 $737,503 - $944,177
-10,798 Reduced 10.79%
89,267 $6.66 Million
Q3 2022

Oct 26, 2022

SELL
$82.37 - $107.29 $419,922 - $546,964
-5,098 Reduced 4.85%
100,065 $8.27 Million
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $1.24 Million - $1.83 Million
-14,286 Reduced 11.96%
105,163 $10 Million
Q1 2022

Apr 22, 2022

BUY
$101.96 - $128.34 $862,173 - $1.09 Million
8,456 Added 7.62%
119,449 $14.1 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $610,138 - $749,580
-5,736 Reduced 4.91%
110,993 $14.4 Million
Q3 2021

Nov 05, 2021

BUY
$102.91 - $122.75 $782,116 - $932,900
7,600 Added 6.96%
116,729 $13.2 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $235,925 - $294,794
-2,814 Reduced 2.51%
109,129 $11.3 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $381,519 - $439,658
4,849 Added 4.53%
111,943 $9.36 Million
Q4 2020

Feb 18, 2021

BUY
$71.69 - $91.23 $368,486 - $468,922
5,140 Added 5.04%
107,094 $9.77 Million
Q3 2020

Nov 05, 2021

BUY
$67.19 - $87.44 $8,465 - $11,017
126 Added 0.12%
101,954 $8.14 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $1.03 Million - $1.34 Million
15,322 Added 17.71%
101,828 $8.13 Million
Q2 2020

Nov 16, 2021

BUY
$57.54 - $76.95 $7,250 - $9,695
126 Added 0.15%
86,506 $5.98 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $3.37 Million - $4.51 Million
58,547 Added 210.35%
86,380 $5.97 Million
Q1 2020

Nov 05, 2021

BUY
$52.41 - $81.0 $2,201 - $3,402
42 Added 0.15%
27,833 $5.25 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $275,624 - $425,979
-5,259 Reduced 15.91%
27,791 $5.24 Million
Q4 2019

Nov 16, 2021

BUY
$71.7 - $82.09 $3,011 - $3,447
42 Added 0.13%
33,050 $7.71 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $2.16 Million - $2.47 Million
30,095 Added 1033.13%
33,008 $7.7 Million
Q3 2019

Oct 31, 2019

SELL
$61.55 - $75.43 $28,928 - $35,452
-470 Reduced 13.89%
2,913 $640,000
Q2 2019

Jul 24, 2019

BUY
$55.74 - $64.41 $26,755 - $30,916
480 Added 16.53%
3,383 $625,000
Q1 2019

Apr 23, 2019

BUY
$47.89 - $64.05 $3,017 - $4,035
63 Added 2.22%
2,903 $556,000
Q4 2018

Jan 22, 2019

SELL
$46.41 - $56.94 $6,822 - $8,370
-147 Reduced 4.92%
2,840 $435,000
Q3 2018

Oct 17, 2018

SELL
$45.7 - $58.03 $44,191 - $56,115
-967 Reduced 24.46%
2,987 $520,000
Q2 2018

Jul 26, 2018

BUY
$42.45 - $51.3 $31,625 - $38,218
745 Added 23.22%
3,954 $576,000
Q1 2018

Apr 20, 2018

SELL
$37.19 - $47.45 $50,169 - $64,010
-1,349 Reduced 29.6%
3,209 $448,000
Q4 2017

Jan 29, 2018

SELL
$33.79 - $39.39 $88,191 - $102,807
-2,610 Reduced 36.41%
4,558 $514,000
Q3 2017

Oct 23, 2017

BUY
$36.29 - $38.83 $260,126 - $278,333
7,168
7,168 $784,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.